Patent
Gelatin containing beta-carotene
Reads0
Chats0
TLDR
A combination of β-carotene and iron oxides as lightfast, opaque colorant of gelatin and their use in foods and pharmaceuticals, in particular in the shell of soft gelatin capsules, is described in this paper.Abstract:
The invention relates to a combination of β-carotene and iron oxides as lightfast, opaque colorant of gelatin and their use in foods and pharmaceuticals, in particular in the shell of soft gelatin capsules.read more
Citations
More filters
Patent
Nifidipine concentrate stabilized against the influence of light, and method for its preparation
TL;DR: In this article, the concentrate contains nifedipine, polyethylene glycol, 0.5 to 20 % by weight of vitamin B2, at least one surfactant and, where appropriate, conventional vehicles.
Patent
Pharmaceutical compositions and methods for producing low impurity concentrations of the same
TL;DR: In this paper, a composition with clevidipine as an active ingredient and an amount of impurity H168/79 that is no greater than about 1.5% was described.
Patent
Food product comprising carotenoids
TL;DR: In this paper, an edible composition, preferably an edible emulsion, which comprises high amounts, e.g. at least 15 mg/kg of one or more coloured carotenoids, but is not coloured in a manner as expected when using such high amounts of carotensoids, as defined by the composition having a yellowness factor of less than 4000 g/kg, and a yowowness index in the range of 1 to 90.
Patent
Solutions of carotenoids for use in foods and personal care products
Holly Johnson,Amanda Ueltschy,Jerry L. Newman,Anthony W. Newman,Jennifer Barker,Zoraida Defreitas,Rod Ausich +6 more
TL;DR: Concentrated solutions of carotenoids in essential oils and cosmetic oils for use in foods, beverages, and personal care products were reported in this paper, where the concentrated solutions comprised between about 8 weight and 15 weight carotensoid in the oil, or between about 15 times and about 100 times the maximum concentration reported in the prior art.
Patent
Pharmaceutical compositions and methods for stabilizing the same
TL;DR: In this paper, a method of stabilizing pharmaceutical compositions having clevidipine, or any pharmaceutically acceptable salt thereof, as the active ingredient is described, including the slowing down or inhibiting of the oxidation pathway of clevidine.
References
More filters
Patent
Coronary dilator in a pharmaceutical dosage unit form
TL;DR: In this paper, an instant oral-release capSUle is described, having a shard of gelatine with a mixture of 4-2-NITROPHENYL, 2-6-DIMETHYL, 3-5-DICARBOMETHOXY, 1,4-DIHYDROPYRIDINE, and 1, 2 or 3 HYDROXY GROUPS.
Patent
Natural dyestuffs for gelatine capsules
TL;DR: In this article, a process for stabilizing dyestuffs sensitive to light and/or oxidation is described, by adsorption on a highly disperse adsorbent, whereby the dyestuff is immobilized.